Please use this identifier to cite or link to this item: 10.1016/j.jtho.2015.12.096
Title: Squamous cell carcinoma "transformation" concurrent with secondary T790M mutation in resistant EGFR-mutated adenocarcinomas
Authors: Jukna, Agita
Montanari, Gloria
Mengoli, Maria Cecilia
Cavazza, Alberto
Covi, Marisa
Barbieri, Fausto
Bertolini, Federica
Rossi, Giulio
Department of Pathology
Keywords: Adenocarcinoma;EGFR;Lung;Squamous cell carcinoma;T790M;3.2 Clinical medicine;1.1. Scientific article indexed in Web of Science and/or Scopus database;Oncology;Pulmonary and Respiratory Medicine
Issue Date: 2016
Citation: Jukna , A , Montanari , G , Mengoli , M C , Cavazza , A , Covi , M , Barbieri , F , Bertolini , F & Rossi , G 2016 , ' Squamous cell carcinoma "transformation" concurrent with secondary T790M mutation in resistant EGFR-mutated adenocarcinomas ' , Journal of Thoracic Oncology , vol. 11 , no. 4 , pp. e49-e51 . https://doi.org/10.1016/j.jtho.2015.12.096
Abstract: The authors report two cases of epidermal growth factor receptor gene (EGFR)-mutant stage IV lung adenocarcinomas developing immunohistochemically proven squamous cell carcinoma (SCC) "transformation" concurrently with T790M EGFR mutation, leading to acquired resistance to EGFR inhibitors. Moreover, the histologic change of EGFR-mutant lung adenocarcinoma into SCC has been recently reported in literature. The histological transformation to SCC appears as a novel mechanism of acquired EGFR TKI resistance in EGFR-mutated adenocarcinomas and it may be challenging for treatment.
Description: Publisher Copyright: © 2016 International Association for the Study of Lung Cancer. Published by Elsevier Inc.
DOI: 10.1016/j.jtho.2015.12.096
ISSN: 1556-0864
Appears in Collections:Research outputs from Pure / Zinātniskās darbības rezultāti no ZDIS Pure

Files in This Item:
File SizeFormat 
Squamous_Cell_Carcinoma_Transformation.pdf679.05 kBAdobe PDFView/Openopen_acces_unlocked


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.